All systems operational
For Researchers For Publishers Login Register
Home Publications Annals of Saudi Medicine
Q2 2025 Vol. 18 · No. 4 · pp. 215-235

Errata

10.5144/0256-4947.2025.144 1,135 Views 0 Citations
0
Citations
1,135
Views
Vol. 18, No.4
Volume / Issue
215-235
Pages
Abstract not available for this publication.
Cite this Article (APA)
(2025). Errata. Annals of Saudi Medicine, 18(4), 215-235. https://doi.org/10.5144/0256-4947.2025.144
Related Papers
Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diab…
Moaz Safwan; Mariam Safwan Bourgleh; Shahad Abdullah Alotaibi; Eman Alotaibi; Ab · 2025
11
cites
1,081
Efficacy and safety of semaglutide: real-world tertiary care experience from Saudi Arabia
Muhammad Imran Butt; Khalid Mania Alkhalifah; Muhammad Riazuddin; Saud Mohammed · 2024
9
cites
1,710
Prevalence of hyponatremia among medically hospitalized patients and associated outcomes: a retrospe…
Intisar Hamood Al Yaqoubi; Juhaina Salim Al-Maqbali; Afnan Ahmed Al Farsi; Rayan · 2024
8
cites
1,983
Estimating the prevalence of select non-communicable diseases in Saudi Arabia using a population-bas…
Suliman Alghnam; Mohammad Bosaeed; Abdulrahman Aljouie; Saeed Mastour Alshahrani · 2024
5
cites
1,932
Access
View Full Text via DOI
Published in
ISSN 0256-4947
Quartile Q2
AMS Score 83
Field Medicine & Health Sciences
Publisher King Faisal Specialist Hospital
Country 🇸🇦 Saudi Arabia
View Journal Profile →
Publication Details
Year 2025
Volume 18
Issue 4
Pages 215-235
Language English
Added 23 Jun 2026